@article{4d60891e5e69419b865aef416b1fe901,
title = "Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial",
abstract = "In the ARISTOTLE trial, the rate of stroke or systemic embolism was reduced by apixaban compared with warfarin in patients with atrial fibrillation (AF). Patients with AF and previous stroke or transient ischaemic attack (TIA) have a high risk of stroke. We therefore aimed to assess the efficacy and safety of apixaban compared with warfarin in prespecified subgroups of patients with and without previous stroke or TIA.",
author = "Easton, {J Donald} and Lopes, {Renato D} and Bahit, {M Cecilia} and Wojdyla, {Daniel M} and Granger, {Christopher B} and Lars Wallentin and Marco Alings and Shinya Goto and Lewis, {Basil S} and M{\aa}rten Rosenqvist and Michael Hanna and Puneet Mohan and Alexander, {John H} and Hans-Christoph Diener and Torp-Pedersen, {Christian Tobias} and Torp-Pedersen, {Christian Tobias}",
note = "Copyright {\textcopyright} 2012 Elsevier Ltd. All rights reserved.",
year = "2012",
month = jun,
doi = "10.1016/S1474-4422(12)70092-3",
language = "English",
volume = "11",
pages = "503--11",
journal = "The Lancet Neurology",
issn = "1474-4422",
publisher = "TheLancet Publishing Group",
number = "6",
}